
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC285a-7]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
              SUBCHAPTER III--NATIONAL RESEARCH INSTITUTES
 
   Part C--Specific Provisions Respecting National Research Institutes
 
                  subpart 1--national cancer institute
 
Sec. 285a-7. Prostate cancer


(a) Expansion and coordination of activities

    The Director of the Institute, in consultation with the National 
Cancer Advisory Board, shall expand, intensify, and coordinate the 
activities of the Institute with respect to research on prostate cancer.

(b) Coordination with other institutes

    The Director of the Institute shall coordinate the activities of the 
Director under subsection (a) of this section with similar activities 
conducted by other national research institutes and agencies of the 
National Institutes of Health to the extent that such Institutes \1\ and 
agencies have responsibilities that are related to prostate cancer.
---------------------------------------------------------------------------
    \1\ So in original. Probably should not be capitalized
---------------------------------------------------------------------------

(c) Programs

                           (1) In general

        In carrying out subsection (a) of this section, the Director of 
    the Institute shall conduct or support research to expand the 
    understanding of the cause of, and to find a cure for, prostate 
    cancer. Activities under such subsection shall provide for an 
    expansion and intensification of the conduct and support of--
            (A) basic research concerning the etiology and causes of 
        prostate cancer;
            (B) clinical research and related activities concerning the 
        causes, prevention, detection and treatment of prostate cancer;
            (C) prevention and control and early detection programs with 
        respect to prostate cancer in accordance with section 285a-1 of 
        this title, particularly as it relates to intensifying research 
        on the role of prostate specific antigen for the screening and 
        early detection of prostate cancer;
            (D) an Inter-Institute Task Force, under the direction of 
        the Director of the Institute, to provide coordination between 
        relevant National Institutes of Health components of research 
        efforts on prostate cancer;
            (E) control programs with respect to prostate cancer in 
        accordance with section 285a-1 of this title;
            (F) information and education programs with respect to 
        prostate cancer in accordance with section 285a-2 of this title; 
        and
            (G) research and demonstration centers with respect to 
        prostate cancer in accordance with section 285a-3 of this title, 
        including the development and operation of centers for prostate 
        cancer research to bring together basic and clinical, biomedical 
        and behavioral scientists to conduct basic, clinical, 
        epidemiological, psychosocial, prevention and control, 
        treatment, research, and related activities on prostate cancer.

    Not less than six centers shall be operated under subparagraph (G). 
    Activities of such centers should include supporting new and 
    innovative research and training programs for new researchers. Such 
    centers shall give priority to expediting the transfer of research 
    advances to clinical applications.

               (2) Implementation of plan for programs

        (A) The Director of the Institute shall ensure that the research 
    programs described in paragraph (1) are implemented in accordance 
    with a plan for the programs. Such plan shall include comments and 
    recommendations that the Director of the Institute considers 
    appropriate, with due consideration provided to the professional 
    judgment needs of the Institute as expressed in the annual budget 
    estimate prepared in accordance with section 285a-2(9) \2\ of this 
    title. The Director of the Institute, in consultation with the 
    National Cancer Advisory Board, shall periodically review and revise 
    such plan.
---------------------------------------------------------------------------
    \2\ So in original. Probably should be section ``285a-2(b)(9)''.
---------------------------------------------------------------------------
        (B) Not later than October 1, 1993, the Director of the 
    Institute shall submit a copy of the plan to the President's Cancer 
    Panel, the Secretary, and the Director of NIH.
        (C) The Director of the Institute shall submit any revisions of 
    the plan to the President's Cancer Panel, the Secretary, and the 
    Director of NIH.
        (D) The Secretary shall provide a copy of the plan submitted 
    under subparagraph (A), and any revisions submitted under 
    subparagraph (C), to the Committee on Energy and Commerce of the 
    House of Representatives and the Committee on Labor and Human 
    Resources of the Senate.

(July 1, 1944, ch. 373, title IV, Sec. 417A, as added Pub. L. 103-43, 
title IV, Sec. 402, June 10, 1993, 107 Stat. 155.)

                         Change of Name

    Committee on Energy and Commerce of House of Representatives treated 
as referring to Committee on Commerce of House of Representatives by 
section 1(a) of Pub. L. 104-14, set out as a note preceding section 21 
of Title 2, The Congress.

                  Section Referred to in Other Sections

    This section is referred to in section 285a-8 of this title.
